1. Home
  2. PDYN vs TRDA Comparison

PDYN vs TRDA Comparison

Compare PDYN & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$7.11

Market Cap

292.0M

Sector

Industrials

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.85

Market Cap

274.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
TRDA
Founded
1983
2016
Country
United States
United States
Employees
70
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.0M
274.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PDYN
TRDA
Price
$7.11
$6.85
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$9.67
$21.00
AVG Volume (30 Days)
2.0M
272.4K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
$384.48
$39.97
Revenue Next Year
$63.16
$50.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$4.93
52 Week High
$12.79
$16.45

Technical Indicators

Market Signals
Indicator
PDYN
TRDA
Relative Strength Index (RSI) 51.70 44.91
Support Level $5.89 $5.75
Resistance Level $7.77 $7.02
Average True Range (ATR) 0.79 0.46
MACD -0.14 0.25
Stochastic Oscillator 36.46 80.80

Price Performance

Historical Comparison
PDYN
TRDA

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: